TLS Polymerases: Genome Plasticity and Cancers - Lab members

Lab members

  • Patricia Kannouche (Directeur de recherche- CNRS), Manager
  • Caroline Pouvelle (TCN CNRS)
  • Emmanuelle Despras (Post-Doc GR)
  • Sana Ahmed-Seguir (PhD student)
  • Noémie Delrieu (PhD student, 4ème année ED Cancérologie, University Paris Sud)
  • Yann Benureau (Engineer d’étude, GR- SIRIC)
  • Mégane Bouvet (Technician, CDD-CNRS)
  • Barbara Ben Yamin (Engineer assitant, CDD-CNRS)

Parrainage chercheur "Cancer du sein"

Doctoral School of Oncology

Doctoral School of Oncology: biological sciences, medicine, health (CBMS – ED 418)

The Doctoral School of Oncology (Ecole Doctorale 418 – Doctoral School 418) was established in 2000 within the Faculty of Medicine - Paris-Sud University in association with the Cachan Ecole Normale Supérieure and Gustave Roussy.

TLS Polymerases: Genome Plasticity and Cancers - Publications

Publications since 2008

  • Sana Ahmed-Seghir, Caroline Pouvelle, Emmanuelle Despras, Agnès Cordonnier, Alain Sarasin and Patricia L Kannouche. Aberrant C-terminal Domain of Polymerase eta Targets the Functional Enzyme to the Proteosomal Degradation Pathway. DNA Repair, in revision.

Parrainage chercheur "Cancer du poumon"

Renal cancer - team

Urology Committee

Chairman: Pr Pierre Blanchard

Oncologists: Pr Laurence Albiges, Dr Alice Bernard Tessier, Dr Solenn Barraud, Dr Mario Di Palma, Dr Bernard Escudier, Dr Alina Fuerea, Dr Ronan Flippot, Pr Yohann Loriot, Dr Natacha Naoun, Dr Anna Patrikidou, Dr Cédric Pobel, Dr Macarena Rey Cardenas

Radiotherapy: Pr Pierre Blanchard, Dr Youssef Ghannam, Dr Mario Terlizzi

Cancer du rein - parcours

Diagnostic

Quel que soit le signe révélateur, le diagnostic est confirmé par des examens cliniques et radiologiques. L'examen clinique est le plus souvent normal. Il peut mettre en évidence une masse dans la région lombaire, régulière ou bosselée, plus ou moins mobile, correspondant à la tumeur.

Le diagnostic est principalement fait sur les examens radiologiques :

Renal cancer

Treatment of renal cancer

Renal cancer is the commonest kidney tumour. This is usually an adenocarcinoma (80% of cases). It is also known as “clear cell carcinoma”. Other malignant kidney tumours are much less common: tubulopapillary or papillary renal cell carcinomas, chromophobe renal cell carcinoma, collecting duct carcinoma, etc.   
Each type of tumour has its own very specific treatment.

Parrainage "Cancer de la peau"

Pages